Literature DB >> 18653257

A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT).

Minoru Suzuki1, Kazuo Endo, Hiroaki Satoh, Yoshinori Sakurai, Hiroaki Kumada, Hiroyuki Kimura, Shinichiro Masunaga, Yuko Kinashi, Kenji Nagata, Akira Maruhashi, Koji Ono.   

Abstract

Two patients, one with malignant pleural mesothelioma and one with a malignant short spindle cell tumor, received boron neutron capture therapy (BNCT). In each case, the tumors regressed or remained stable in size for 3-6 months following BNCT. No acute or late adverse events higher than grade 2 were observed.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18653257     DOI： 10.1016/j.radonc.2008.06.009

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  8 in total

1.  Boron neutron capture synovectomy (BNCS) as a potential therapy for rheumatoid arthritis: boron biodistribution study in a model of antigen-induced arthritis in rabbits.

Authors:  Verónica A Trivillin; David B Abramson; Gaston E Bumaguin; Leandro J Bruno; Marcela A Garabalino; Andrea Monti Hughes; Elisa M Heber; Sara Feldman; Amanda E Schwint
Journal:  Radiat Environ Biophys       Date:  2014-08-26       Impact factor: 1.925

Review 2.  Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era.

Authors:  Minoru Suzuki
Journal:  Int J Clin Oncol       Date:  2019-06-05       Impact factor: 3.402

3.  Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy.

Authors:  Tomoki Kimura; Yoshiko Doi; Takeo Nakashima; Nobuki Imano; Tsuyoshi Katsuta; Shigeo Takahashi; Masahiro Kenjo; Shuichi Ozawa; Yuji Murakami; Yasushi Nagata
Journal:  J Radiat Res       Date:  2015-01-18       Impact factor: 2.724

Review 4.  Boron Neutron Capture Therapy: A Review of Clinical Applications.

Authors:  Timothy D Malouff; Danushka S Seneviratne; Daniel K Ebner; William C Stross; Mark R Waddle; Daniel M Trifiletti; Sunil Krishnan
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

5.  Induced radioactivity in the blood of cancer patients following Boron Neutron Capture Therapy.

Authors:  Keiko Fujiwara; Yuko Kinashi; Tomoyuki Takahashi; Hiroshi Yashima; Kouta Kurihara; Yoshinori Sakurai; Hiroki Tanaka; Koji Ono; Sentaro Takahashi
Journal:  J Radiat Res       Date:  2013-02-07       Impact factor: 2.724

6.  Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [18F]-L-FBPA positron emission tomography in boron neutron capture therapy.

Authors:  Tsubasa Watanabe; Yoshihide Hattori; Youichiro Ohta; Miki Ishimura; Yosuke Nakagawa; Yu Sanada; Hiroki Tanaka; Satoshi Fukutani; Shin-Ichiro Masunaga; Masahiro Hiraoka; Koji Ono; Minoru Suzuki; Mitsunori Kirihata
Journal:  BMC Cancer       Date:  2016-11-08       Impact factor: 4.430

7.  In vitro and in vivo BNCT investigations using a carborane containing sulfonamide targeting CAIX epitopes on malignant pleural mesothelioma and breast cancer cells.

Authors:  Diego Alberti; Alessia Michelotti; Alberto Lanfranco; Nicoletta Protti; Saverio Altieri; Annamaria Deagostino; Simonetta Geninatti Crich
Journal:  Sci Rep       Date:  2020-11-06       Impact factor: 4.379

8.  Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system.

Authors:  Naonori Hu; Hiroki Tanaka; Ryo Kakino; Syuushi Yoshikawa; Mamoru Miyao; Kazuhiko Akita; Kayako Isohashi; Teruhito Aihara; Keiji Nihei; Koji Ono
Journal:  Radiat Oncol       Date:  2021-12-24       Impact factor: 3.481
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.